Summit Features a Select Group of 40 Promising Healthcare Companies at Premier Small-Cap Investor Event OAK RIDGE, TN, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces that President and Chief Executive Officer Michael Feldschuh will engage institutional investors at the Maxim Growth Summit presented by Maxim Group LLC. The Summit is being held on October 22 – 23, 2025, at the Hard Rock Hotel in New York City. Mr. Fe ...

OAK RIDGE, Tenn., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ: DXR), the global leader in blood volume measurement technology, today announces it will be exhibiting at the MedAxiom Cardiovascular (CV) Transforum Fall’25 Conference being held at the JW Marriott Austin, from Thursday, October 16 - Saturday, October 18 in Austin, TX. The CV Transforum is the leading conference for cardiovascular organizational performance solutions, uniting industry innovators and thought leaders from across th ...

公司技术与产品进展 - 公司推出新获得FDA批准的新一代BVA分析仪，标志着数据驱动体液管理进入新纪元，面向一个价值数十亿美元的市场 [1] - 新系统因其易用性、速度和超过95%的准确率，获得了临床医生的初步积极响应，证实了强劲的市场需求 [2] - 公司拥有50年经验，在美国运营一个20,000平方英尺的先进制造工厂，并获得ISO认证，为加速市场扩张奠定基础 [4] 临床验证与商业机会 - 在美国心力衰竭学会年会上公布的三项来自领先机构的新临床数据，进一步验证了公司BVA技术在高成本患者群体中的价值 [3] - 临床数据显示，经BVA优化管理的患者实现了零非计划再入院，而未达到血液容量平衡的患者再入院率高达57%至77% [7] - 首席医疗官表示，强大的临床验证结合更快速、更易用的分析仪，使公司处于理想位置，有望在数十亿美元市场中占据重要商业份额 [3] 具体临床研究结果 - Banner大学医学中心研究证实，通过BVA测试达到最佳总血容量和红细胞容量平衡的心衰患者，其非计划再入院率为零 [7] - Wellstar健康系统的研究显示，在左心室辅助装置植入术前后采用BVA指导护理，将30天生存率从90.3%提升至93.6%，1年生存率从79.6%提升至87.8% [7] - 同一研究还表明，BVA指导护理将30天再入院率从28.6%降低至18.5%，并将术后住院时间缩短了1.5天 [7] - Geisinger医疗中心的新数据证实，心脏淀粉样变性患者的总血容量和血浆容量显著更高，BVA有助于诊断此独特表型，辅助临床医生精确利尿剂用量 [7]

Oak Ridge, TN, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces today that CEO and President Michael Feldschuh will present at the H.C. Wainwright 27th Annual Global Investment Conference being held on September 8-10, 2025 in New York City at the Lotte New York Palace Hotel. The presentation will be available on-demand beginning Friday, September 5 at 7:00 a.m. ET. Investors who wish to listen to the Company’s presentatio ...